Ultragenyx Pharmaceutical Inc - Company Profile
Powered by 
All the sales intelligence you need on Ultragenyx Pharmaceutical Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Ultragenyx Pharmaceutical Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Ultragenyx Pharmaceutical Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Ultragenyx Pharmaceutical Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Ultragenyx Pharmaceutical Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Daniel G. Welch
Chairman Executive BoardMr. Daniel G. Welch has been the Chairman of the company since 2015. Prior to this, he served as the Chairman, Chief Executive Officer, and President of InterMune. Mr. Welch also served as the Chairman and Chief Executive Officer at Triangle Pharmaceuticals Inc; President of the Pharmaceutical Division at Elan Corporation, PLC. Currently, he serves on the boards of directors of Seattle Genetics and Hyperion Therapeutics and Executive Partner at Sofinnova Ventures.
Emil D. Kakkis, M.D., Ph.D.
Chief Executive Officer; Director; President Executive BoardDr. Emil D. Kakkis has been the Director, President, and Chief Executive Officer of the company since 2010. Prior to this, he served as the Chief Medical Officer and Development Consultant at BioMarin Pharmaceutical Inc. Dr. Kakkis also served as the Board Member at National Organization for Rare Disorders. Currently, he serves as the President at EveryLife Foundation for Rare Diseases and Director of Odylia Therapeutics.
Howard Horn
Chief Financial Officer; Executive Vice President - Corporate Strategy Senior ManagementMr. Howard Horn has been the Chief Financial Officer and Executive Vice President of the company since 2023. Prior to this, he served as the Chief Financial Officer of Vir Biotechnology. Previously, he served as the Vice President of Strategic Corporate Finance at Biogen. He also served in various roles at McKinsey & Company.
Eric Crombez
Executive Vice President; Chief Medical Officer Senior ManagementMr. Eric Crombez has been the Executive Vice President and Chief Medical Officer of the company since 2023. Prior to this, he served as the Chief Medical Officer for Gene Therapy and Inborn Errors of Metabolism of the company. Previously, he served at Shire in its Human Genetics Therapy business unit.
Erik Harris
Chief Commercial Officer; Executive Vice President Senior ManagementMr. Erik Harris has been the Executive Vice President and Chief Commercial Officer of the company since 2019. Prior to this, he served as the Senior Vice President and Head of North American Commercial Operations. Mr. Harris served in several leadership positions at Crescendo Bioscience, including Vice President of Commercial. Prior to this, he served as the Vice President of Pulmonology Marketing at Intermune Inc.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer